INSIGHTS ON DRUG DISCOVERY

Discovery, Characterization Of Epitope-Diverse MMR Protein Antibodies
Learn how these high-affinity, epitope-diverse mAbs provide a powerful toolkit to dissect the role of DNA mismatch repair (MMR) proteins in HD.
Mammalian Expression
See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges.
Balancing Timelines In Outsourced R&D With GXP Compliance
Outsourced R&D balances speed and quality by integrating strong governance, clear planning, and GXP compliance, enabling efficient execution while reducing risk, rework, and development delays.
Integrated Drug Discovery: Hit To PCC In 16 Months
Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.

ADC Development Grows More Complex — SPR Insights Bring Clarity
4/14/2026

Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
Mammalian Cell Line Development
3/26/2026

Explores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.
WuXia293Stable: Express What CHO Can't
3/26/2026

Discover a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.
What Matters More In DNA-Encoded Libraries?
3/16/2026

DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.
Translating Massive Data Into Therapeutic Momentum
3/13/2026

New advances in chemomics, proteome mapping, and modern synthetic methods are redefining how quickly and precisely discovery teams can move from raw data to meaningful clinical momentum.

DRUG DISCOVERY SOLUTIONS

A Fully Integrated Toolbox For Therapeutic Protein Expression

The GS Xceed^® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.
Biological And Functional Assays

Curia provides a wide range of biochemical and cell-based bioassay workflows to support Discovery, Research & Development as well as cGxP therapeutic testing campaigns
Analytical Labs Particle Analysis

Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.
CRISPR/Cas9 And Cas9 Variants

A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.
Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing

Continuous biomanufacturing boosts speed, flexibility, and control. Modular automation, intensified processing, and streamlined workflows drive productivity and consistent quality.